GREY:IMVIF - Post by User
Comment by
qwerty22on May 15, 2020 12:33pm
112 Views
Post# 31034099
RE:RE:RE:That's it. Delay in data collecting.
RE:RE:RE:That's it. Delay in data collecting. I guess one other point on peer review is if as Fred hinted this data is potentially high impact then they could secure a good journal which would secure a lot more publicity.
Lots of "ifs" there.
qwerty22 wrote:
correction - if the gov WASNT on-board as a partner then they wouldn't proceed.
qwerty22 wrote:
Good early spot by you on the basket trial delay.
On the cc
Mostly frustration on the slowing pace of all the oncology programs.
Ovarian mono - the focus now on durability really speaks to me about the fact that the ORR is just not good enough. Well not good enough to carry the program alone, honestly if the ORR was good enough they wouldn't be waiting for the durability data.
dlbcl - Again the issue is fast responder and how to deal with them. If this trial ever gets completed looks like the next trial will try to tackle that issue.
basket - I guess we all now know the situation with that.
Covid - I thought they could have given a sneak peek at the preliminary data but I guess it's now silence until they publish the data. The plan to publish has positive and negatives. It going to cause a short delay in communicating the results (I know peer review around covid is happening super quick though), on the plus side we should get a deeper dive into the data from a peer-reviewed paper than a press release. Good news is they are still on track for timing of the trial. Interesting take on gov position. Essentially did he say if the gov was onboard as a partner then they wouldn't proceed? I take it from that they are fairly confident that the gov (and grants) will be there.
Breakthorough1 wrote: "As of May 7, 2020, a total of 92 patients out of the planned 184 patients were enrolled across all five indications at 19 clinical sites in Canada and the US. The COVID-19 pandemic has impacted data collection and validation processes and IMV now anticipates reporting updated results from this study in the second half of 2020." https://www.businesswire.com/news/home/20200515005219/en/